Regeneron Pharmaceuticals Inc REGN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:41 PM EST
451.13quote price arrow down-7.47 (-1.63%)
Volume
752,237
52 week range
418.01 - 664.64

...

Loading . . .

KEY STATS

  • Open460.31
  • Day High465.00
  • Day Low448.33
  • Prev Close458.60
  • 52 Week High664.64
  • 52 Week High Date07/20/20
  • 52 Week Low418.01
  • 52 Week Low Date03/13/20
  • Market Cap48.33B
  • Shares Out107.13M
  • 10 Day Average Volume1.21M
  • Dividend-
  • Dividend Yield-
  • Beta0.12
  • 1 Year % Change2.14

RATIOS/PROFITABILITY

  • EPS (TTM)30.69
  • P/E (TTM)14.70
  • Fwd P/E (NTM)10.96
  • EBITDA (MRQ)3.812B
  • ROE (MRQ)31.77%
  • Revenue (MRQ)8.497B
  • Gross Margin (MRQ)86.82%
  • Net Margin (MRQ)41.35%
  • Debt To Equity (MRQ)24.45%

EVENTS

  • Earnings Date05/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

QUOTE FINDER

Related Video

VIDEO2:1302:13
Regeneron antibody cocktail works against UK and South African variants, study finds

Profile

MORE
Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases....
P. Roy Vagelos M.D.
Chairman
Leonard Schleifer M.D., Ph.D.
President
George Yancopoulos M.D., Ph.D.
Co-President
Robert Landry
Chief Financial Officer
Daniel Van Plew
Executive Vice President
Christopher Fenimore
Vice President
Address
777 Old Saw Mill River Rd
Tarrytown, NY
10591-6717
United States